Alternatively, the S29-leiomiosarcoma responded initially to the CDK4 inhibitor, but after ending the treatment, tumor growth recovered, and the survival of the treated mice was only slightly longer than that of the untreated controls (Figure 6). The gene discussed is CDK4; the disease is neoplasm.